Literature DB >> 12817896

Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells.

Salvatore Cisternino1, Christophe Rousselle, Aurelio Lorico, Germana Rappa, Jean-Michel Scherrmann.   

Abstract

PURPOSE: The purpose of this work was to determine mrpl-mediated efflux across the luminal membrane of endothelial cells at the blood-brain barrier (BBB) in mice.
METHODS: The transport of radiolabeled etoposide, 17beta-estradiol-D-17beta-glucuronide (E217betaG), vincristine, and doxorubicin across the BBB of mrp1(-/-) and wild-type mice was evaluated by in situ brain perfusion. Etoposide transport was also determined in P-glycoprotein-deficient mdr1a(-/-) mice perfused with both etoposide and mrpl inhibitors like probenecid or MK571. Cerebral vascular volume was determined by co-perfusion with labeled sucrose.
RESULTS: Sucrose perfusion indicated that the vascular space was close to normal in all the studies, indicating that the BBB remained intact. The transport of etoposide, E217betaG, vincristine, and doxorubicin into the brain was not affected by the lack of mrp1. Trans-efflux studies in mrp1-deficient mice with etoposide and E217betaG confirmed that mrpl was not involved in the efflux of these substrates across the BBB. There was also a significant P-gp-mediated efflux of etoposide in studies with P-glycoprotein-deficient mdr1a(-/-) mice. Perfusion of mdr1a(-/-) mice etoposide plus probenecid or MK571 did not affect the brain transport of etoposide.
CONCLUSION: Efflux mediated by mrp1 does not seem to occur across the luminal membrane of the endothelial cells forming the mouse BBB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817896     DOI: 10.1023/a:1023895404929

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

1.  Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics.

Authors:  N Strazielle; J F Ghersi-Egea
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 2.  The roles of P-glycoprotein and MRP1 in the blood-brain and blood-cerebrospinal fluid barriers.

Authors:  A H Schinkel
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

3.  Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells.

Authors:  Y Zhang; H Han; W F Elmquist; D W Miller
Journal:  Brain Res       Date:  2000-09-08       Impact factor: 3.252

4.  Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

Authors:  D S Miller; S N Nobmann; H Gutmann; M Toeroek; J Drewe; G Fricker
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

5.  Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution.

Authors:  D E Burgio; M P Gosland
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

6.  Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1.

Authors:  K Nagata; M Nishitani; M Matsuo; N Kioka; T Amachi; K Ueda
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

7.  Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

Authors:  V V Rao; J L Dahlheimer; M E Bardgett; A Z Snyder; R A Finch; A C Sartorelli; D Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats.

Authors:  Kazumasa Naruhashi; Ikumi Tamai; Natsuko Inoue; Hiromi Muraoka; Yoshimichi Sai; Nagao Suzuki; Akira Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

9.  Multidrug resistance-associated protein-1 functional activity in Calu-3 cells.

Authors:  K O Hamilton; E Topp; I Makagiansar; T Siahaan; M Yazdanian; K L Audus
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

10.  Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles.

Authors:  Q Mao; R G Deeley; S P Cole
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

View more
  16 in total

1.  Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.

Authors:  Hisham Qosa; Alaa H Abuznait; Ronald A Hill; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood-brain barrier.

Authors:  Tuan Minh Do; Mélissa Ouellet; Frédéric Calon; Giovanna Chimini; Hélène Chacun; Robert Farinotti; Fanchon Bourasset
Journal:  Mol Cell Biochem       Date:  2011-06-10       Impact factor: 3.396

Review 3.  Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Authors:  Eva Bakos; László Homolya
Journal:  Pflugers Arch       Date:  2006-12-23       Impact factor: 3.657

Review 4.  PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.

Authors:  Severin Mairinger; Thomas Erker; Markus Muller; Oliver Langer
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

5.  Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.

Authors:  Oksana Tsinman; Konstantin Tsinman; Na Sun; Alex Avdeef
Journal:  Pharm Res       Date:  2010-10-14       Impact factor: 4.200

6.  P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.

Authors:  Claude Dagenais; Alex Avdeef; Oksana Tsinman; Adam Dudley; Richard Beliveau
Journal:  Eur J Pharm Sci       Date:  2009-07-08       Impact factor: 4.384

7.  Mechanisms of glutathione-conjugate efflux from the brain into blood: Involvement of multiple transporters in the course.

Authors:  Toshimitsu Okamura; Maki Okada; Tatsuya Kikuchi; Hidekatsu Wakizaka; Ming-Rong Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-22       Impact factor: 6.200

Review 8.  Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2018-10-19

Review 9.  Role of ABC transporters in the pathogenesis of Alzheimer's disease.

Authors:  Alaa H Abuznait; Amal Kaddoumi
Journal:  ACS Chem Neurosci       Date:  2012-10-11       Impact factor: 4.418

Review 10.  The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease.

Authors:  Tapan Behl; Ishnoor Kaur; Aayush Sehgal; Arun Kumar; Md Sahab Uddin; Simona Bungau
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.